http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106831711-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106831711-B
titleOfInvention Benzo [ e ] [1,2,4] triazine-1-oxy derivatives, and compositions and uses thereof
abstract The invention relates to 3- [ (7-chloroquinoline-4-amino) butylamine shown as a formula (1)]-7-substituted-benzo [ e][1,2,4]Triazine-1-oxo derivatives, pharmaceutically acceptable salts, esters, solvates thereof: R 1 selected from hydrogen, hydroxy, C 1 ‑C 6 Alkyl, fluoro, chloro and bromo; r 2 Selected from hydrogen, C 1 ‑C 12 Alkyl or hydroxy; r 3 Selected from hydrogen, C 1 ‑C 12 Alkyl or hydroxy. The invention also provides a composition which comprises the 3- [ (7-chloroquinoline-4-amino) butylamine group shown as the formula (1)]-7-substituted-benzo [ e][1,2,4]Triazine-1-oxo derivatives, pharmaceutically acceptable salts, esters, solvates and pharmaceutically acceptable adjuvants thereof: wherein R is 1 Selected from hydrogen, hydroxy, C 1 ‑C 6 Alkyl, fluoro, chloro or bromo; r 2 Selected from hydrogen, C 1 ‑C 12 Alkyl or hydroxy; r 3 Selected from hydrogen, C 1 ‑C 12 Alkyl or hydroxy. The invention also claims 3- [ (7-chloroquinoline-4-amino) butylamine]-7-substituted-benzo [ e][1,2,4]Triazine-1-oxygen derivatives, and pharmaceutically acceptable salts, esters and solvates thereof are applied to preparation of tumor treatment medicines.
priorityDate 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026846-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15148285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21594886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409263959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420127855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419724261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449341230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398661

Total number of triples: 41.